Tiffany & Co. (TIF): Reiterating Underperform Despite Improving Luxury Trends - Wells Fargo
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Wells Fargo analyst, Ike Bucherow, reiterated his Underperform rating on shares of Tiffany & Co. (NYSE: TIF) but raised his price target to $65 from $61 noting that the outlook for TIF’s 2H has "clearly improved" over the past few months as a steady stream of “less negative” luxury data points (global luxury companies, Swiss Watch exports, Asia jewelry market, etc.) has investors more bullish on TIF’s prospects for improving comp trends for the first time in over a year.
However, he isn't ready to raise his estimate since the stock is fully reflecting an improving trend (TIF +33% from the lows vs. SPX +4%). He also points out the following causes for concern: 1) key currencies have moved lower against the USD over the past few months (weakness in JPY/GBP/EUR which represent around 30% of global mix – all down 5-8%) and 2) Donald Trump’s election victory may cause an unforeseen headwind to the business in Q4 - as TIF’s most productive location in the world (their 5th Avenue Flagship which accounts for 20% of U.S. sales) sits next to Trump Tower and is currently surrounded by meaningful disruption which could linger through the holidays (due to increased Trump security and political protesting).
Shares of Tiffany & Co. closed at $75.96 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Cuts Price Target on Workday (WDAY) Following 3Q; Reiterates Outperform
- Jefferies Raises Price Target on US Physical Therapy (USPH) to $63 Following 12-Clinic Acquisition
- Jefferies Cuts Price Target on Eros Int'l (EROS) to $18 Following Multi-Year Deal
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst PT Change
Related EntitiesDonald J. Trump, Wells Fargo
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!